Dan McKay

The life sciences industry escaped much of the immediate impact of President Donald Trump's market-shaking tariff order, but the relief may not last long. A look at how drugmakers may respond: https://t.co/c0nIopXcNv

A Rhode Island federal judge on Thursday barred the Trump administration from moving forward for now with the termination of billions of dollars in grants supporting state public health programs https://t.co/iDE67NqH5d

State attorneys general are expected to ramp up their False Claims Act enforcement amid the federal push to cut spending and potentially shift some Medicaid costs onto states https://t.co/s5YvCVJozm

Twenty-three states and the District of Columbia on Tuesday accused the Trump administration of illegally terminating about $11 billion in public health funding, causing layoffs and "chaos" in public health agencies across the country https://t.co/SSmiFGwQ2q

Even if reviewers and inspectors are spared, outside experts say FDA job cuts could damage drug development https://t.co/eaQFTraZo1

Concerns about morale and impact on critical functions surface as HHS announces plans to downsize workforce by 24% https://t.co/eaQFTrbxdz

A Virginia hospital faces rare criminal charges after an ex-doctor was accused of falsely telling patients they had cancer and rushing them into surgery. The doc is in prison, and the hospital is under indictment. A look at the unusual case: https://t.co/emcKr8d3gV

The long-term future of Medicaid programs that provide nutrition, transportation and other help is in doubt following the Trump administration's repeal of guidance on how to address health-related social needs https://t.co/M8qHzlfSsJ

The U.S. Department of Health and Human Services on Thursday moved to reinstate about 15 attorneys who were cut loose in recent weeks, restoring staff many in the agency saw as critical to clearing a backlog of Medicare appeals. Story w/@jesse_yeji: https://t.co/1nkHvShKyK

Federal prosecutors are expanding their use of the False Claims Act to target pharmacies accused of contributing to the opioid crisis, a legal strategy that exposes the defendants to hefty penalties, according to a new Bass Berry & Sims report https://t.co/FNIcghr7by

The reversal at HHS of a longstanding commitment to robust public engagement clears the way for fast-paced changes to Medicaid and other massive programs, putting more pressure on compliance officers and sending more lobbying work behind closed doors https://t.co/hWUKVjmacv

President Trump's executive order to sharpen enforcement of healthcare price transparency regulations is a "warning bell" that hospitals and health plans may face stiffer fines and tighter deadlines as they evaluate how to disclose complex data https://t.co/gMqV0DWJxD

HHS is terminating more than a dozen attorneys tasked with reducing a backlog of thousands of Medicare appeals at an internal administrative board. Story w/@jesse_yeji on the impact, how firings were handled: https://t.co/UYn8EVCi1J

A year after a massive data breach disrupted healthcare nationwide, hospitals and other providers are engaged in an "arms race" against hackers as they navigate tough budget choices and remain vulnerable to cyberattacks https://t.co/6TxSpe7Hdv

A First Circuit decision extended a winning streak for the False Claims Act defense bar. The decision's ultimate impact on fraud prosecutions will be shaped by how whistleblowers adjust their legal strategy https://t.co/S52GA6t3Tl

The historic influx of federal spending on pandemic relief and infrastructure projects helped fuel a record-breaking wave of whistleblower lawsuits launched under the False Claims Act last year. A look at what did -- and didn't -- contribute to the trend: https://t.co/7RsHYcGilK

I'm a health law reporter covering the FDA. If any current or former employees (especially attorneys) want to talk about what's happening inside the agency, I'm all ears: (505) 331-4735, [email protected]. Available on signal.